Gene array analysis of clear cell renal cell carcinoma tissue versus matched normal kidney tissue
Currently there is a lack of effective therapies which result in long-term durable response for patients presenting with advanced and metastatic clear cell renal cell carcinoma (ccRCC). This is due in part to a lack of molecular factors which can be targeted pharmacologically. In order to identify novel tumor-specific targets, we performed high throughput gene array analysis screening numerous patient ccRCC tumor tissues across all stages of disease, and compared their gene expression levels to...
Provenance — who produced it, who reused it
Linked to 123 papers in the literature. Roles are inferred factual signals (who deposited the data vs who reused it), with counts — never a judgement about any author.
- LncRNA-SARCC suppresses renal cell carcinoma (RCC) progression v... 2017 · 174 cites
- Long noncoding RNA SNHG12 promotes tumour progression and suniti... 2020 · 136 cites
- A positive feed-forward loop between LncRNA-URRCC and EGFL7/P-AK... 2019 · 124 cites
- FTO-mediated autophagy promotes progression of clear cell renal... 2022 · 107 cites
- Multi-omics identification of an immunogenic cell death-related... 2023 · 103 cites
- The roles of ferroptosis regulatory gene SLC7A11 in renal cell c... 2021 · 81 cites
- Epithelial tumor suppressor ELF3 is a lineage-specific amplified... 2019 · 71 cites
72 further papers cite this accession but reuse could not be confirmed.
Deep data QC
metadata only · no data-level QC for this typeStandardized, field-standard QC computed by touching the data — every metric states how it was obtained
measured = computed from the data · extrapolated/reported = derived or from the repository · dq-1.0 · provisional — verify independently